Correlation Between Bone Biologics and Nu Med

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Nu Med Plus, you can compare the effects of market volatilities on Bone Biologics and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Nu Med.

Diversification Opportunities for Bone Biologics and Nu Med

0.8

Correlation Coefficient

Bone Biologics  Nu Med

Very poor diversification

The 3 months correlation between Bone and NUMD is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Bone Biologics i.e., Bone Biologics and Nu Med go up and down completely randomly.

Pair Corralation between Bone Biologics and Nu Med

Assuming the 90 days horizon Bone Biologics Corp is expected to generate 1.85 times more return on investment than Nu Med. However, Bone Biologics is 1.85 times more volatile than Nu Med Plus. It trades about 0.06 of its potential returns per unit of risk. Nu Med Plus is currently generating about -0.06 per unit of risk. If you would invest  6,050  in Bone Biologics Corp on September 27, 2024 and sell it today you would lose (3,270) from holding Bone Biologics Corp or give up 54.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Bone Biologics Corp  vs.  Nu Med Plus

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Nu Med Plus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Bone Biologics and Nu Med

The main advantage of trading using opposite Bone Biologics and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.

The idea behind Bone Biologics Corp and Nu Med Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..